Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantinos Tsatalas

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Hematology (Amsterdam, Netherlands)|October 22, 2009
Pregnancy in beta-thalassemia trait carriers: an uneventful journeyConstantinos Tsatalas, Panagiota Chalkia, Despoina Pantelidou, et al.
Cases Journal|November 18, 2009
Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: a case reportAthanasios Anastasiadis, Dimitrios Margaritis, Ioannis Kotsianidis, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 10, 2011
Perfusion parameters analysis of the vertebral bone marrow in patients with Ph¹⁻ chronic myeloproliferative neoplasms (Ph(neg) MPN): a dynamic contrast-enhanced MRI (DCE-MRI) studyNikos Courcoutsakis, Athina Spanoudaki, Thomas G Maris, et al.
Leukemia & Lymphoma|January 19, 2008
Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphomaTheofanis Economopoulos, Amanda Psyrri, George Fountzilas, et al.
Histology and Histopathology|December 8, 2016
Expression of the activation markers Blimp1, Foxp1 and pStat3 in extranodal diffuse large B-cell lymphomasGeorgios Petrakis, Ioannis Kostopoulos, Ioannis Venizelos, et al.
Hemoglobin|December 23, 2011
Phenotype and genotype frequency of β-thalassemia and sickle cell disease carriers in Halkidiki, Northern GreeceChristoforos Kalleas, Kostas Anagnostopoulos, Klio Sinopoulou, et al.
Clinical Biochemistry|April 20, 2007
Effect of HbS in the determination of HbA2 with the Biorad Variant II analyzerChristoforos Kalleas, Ioannis Tentes, Dimitrios Margaritis, et al.
Clinical Biochemistry|January 2, 2007
Effect of HbS in the determination of HbA(2) with the TOSOH HLC-723G7 analyzer and the HELENA Beta-Thal Quik column kitChristoforos Kalleas, Ioannis Tentes, Dimitrios Margaritis, et al.
Leukemia & Lymphoma|October 31, 2006
Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG)George Papaxoinis, Sotirios Papageorgiou, Dimitra Rontogianni, et al.
The Oncologist|October 27, 2005
Multifocal extranodal non-hodgkin lymphoma: a clinicopathologic study of 37 cases in Greece, a Hellenic Cooperative Oncology Group studyTheofanis Economopoulos, Sotirios Papageorgiou, Dimitra Rontogianni, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Hematology (Amsterdam, Netherlands)|October 22, 2009
Pregnancy in beta-thalassemia trait carriers: an uneventful journeyConstantinos Tsatalas, Panagiota Chalkia, Despoina Pantelidou, et al.
Cases Journal|November 18, 2009
Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: a case reportAthanasios Anastasiadis, Dimitrios Margaritis, Ioannis Kotsianidis, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 10, 2011
Perfusion parameters analysis of the vertebral bone marrow in patients with Ph¹⁻ chronic myeloproliferative neoplasms (Ph(neg) MPN): a dynamic contrast-enhanced MRI (DCE-MRI) studyNikos Courcoutsakis, Athina Spanoudaki, Thomas G Maris, et al.
Leukemia & Lymphoma|January 19, 2008
Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphomaTheofanis Economopoulos, Amanda Psyrri, George Fountzilas, et al.
Histology and Histopathology|December 8, 2016
Expression of the activation markers Blimp1, Foxp1 and pStat3 in extranodal diffuse large B-cell lymphomasGeorgios Petrakis, Ioannis Kostopoulos, Ioannis Venizelos, et al.
Hemoglobin|December 23, 2011
Phenotype and genotype frequency of β-thalassemia and sickle cell disease carriers in Halkidiki, Northern GreeceChristoforos Kalleas, Kostas Anagnostopoulos, Klio Sinopoulou, et al.
Clinical Biochemistry|April 20, 2007
Effect of HbS in the determination of HbA2 with the Biorad Variant II analyzerChristoforos Kalleas, Ioannis Tentes, Dimitrios Margaritis, et al.
Clinical Biochemistry|January 2, 2007
Effect of HbS in the determination of HbA(2) with the TOSOH HLC-723G7 analyzer and the HELENA Beta-Thal Quik column kitChristoforos Kalleas, Ioannis Tentes, Dimitrios Margaritis, et al.
Leukemia & Lymphoma|October 31, 2006
Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG)George Papaxoinis, Sotirios Papageorgiou, Dimitra Rontogianni, et al.
The Oncologist|October 27, 2005
Multifocal extranodal non-hodgkin lymphoma: a clinicopathologic study of 37 cases in Greece, a Hellenic Cooperative Oncology Group studyTheofanis Economopoulos, Sotirios Papageorgiou, Dimitra Rontogianni, et al.
Pageof 2